| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xtant Medical Holdings, Inc. (XTNT) has 8 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. XTNT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 7.52M | $4.28M | - | |
| CFO | 843.4K | $480.7K | - | |
| CEO | 789.9K | $450.2K | - | |
| COO | 663.2K | $378.0K | - | |
| Dir | 517.6K | $295.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2016 | Goldberger Daniel S69 | Chief Executive Officer | Buy | 5,000 | $2.34 | $11,700.00 | +6.1% | |
| Dec 3, 2015 | Swanson Kent L | Director | Buy | 3,300 | $2.83 | $9,343.00 | +1.0% | |
| Nov 20, 2015 | Kirschman David Louis | EVP &Chief Scientific Officer | Buy | 2,000 | $2.99 | $5,982.60 | - | |
| Nov 20, 2015 | Swanson Kent L | Director | Buy | 5,000 | $3.00 | $14,997.60 | +3.3% | |
| Nov 19, 2015 | Kirschman David Louis | EVP &Chief Scientific Officer | Buy | 2,000 | $2.90 | $5,805.00 | - | |
| Nov 16, 2015 | Goldberger Daniel S69 | Chief Executive Officer | Buy | 3,000 | $2.80 | $8,400.00 | +24.0% | |
| Sep 4, 2015 | Goldberger Daniel S69 | Chief Executive Officer | Buy | 81,522 | $3.68 | $300,000.96 | New | |
| Sep 4, 2015 | Wickwire Jon M. | Director | Buy | 10,869 | $3.68 | $39,997.92 | +53.3% | |
| Sep 4, 2015 | Swanson Kent L | Director | Buy | 30,000 | $3.68 | $110,400.00 | +66.9% | |
| Sep 4, 2015 | Lopach Michael A | Director | Buy | 10,869 | $3.68 | $39,997.92 | +320.7% |